Both in Pharmaceuticals
Omeros vs Opko Health
Over the past year OMER returned +148.7% and OPK returned +22.9%; their daily moves had a correlation of 0.03.
OMER +148.7% OPK +22.9%Growth of $1, one year, split-adjusted
| Metric | OMER | OPK |
|---|---|---|
| Price | $17.83 | $1.72 |
| Market cap | $1.29B | $1.28B |
| Today | −3.31% | +3.61% |
| 1 month | −4.2% | +10.3% |
| 6 months | +19.6% | +55.0% |
| Year to date | +3.8% | +36.5% |
| 1 year | +137.1% | +17.8% |
| Revenue growth (YoY) | — | +4.3% |
| Gross margin | 97.2% | 48.9% |
| Net margin | 46.4% | −5.1% |
| P/E (TTM) | 10.3× | — |
| Price / sales | 33.6× | 2.2× |
| Net cash | $58.7M | -$46.5M |
| Dividend yield | — | — |
| Volatility (60d) | 76.7% | 57.4% |
| Short % of float | 17.8% | 9.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).